Tapewire

Nasdaq · USD

NKTX

Nkarta, Inc.

Export transactions ↓
Tapewire entity
6346
SEC CIK
0001787400
Parsed reports
218

Last 12 months

Inside the activity.

0 purchase rows · 3 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202500
Dec 202500
Jan 202602
Feb 202600
Mar 202600
Apr 202600
May 202600
Jun 202601
Jul 202600
Aug 202600
Sep 202600
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
January 14, 2022 Filed Jan 19, 2022 16:52 UTC
Rajangam KanyaChief Medical Officer
GrantStock Option (right to buy) · Derivative 76,800 $0.00 Strike: $12.14 $0.00
Disclosure

SEC source: 0001209191-22-003756 · doc4.xml · derivative · entry 2

Rajangam Kanya · CIK 0001816676 · Chief Medical Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 76,800

Underlying: Common Stock · 76,800 shares

Expires 2032-01-13

F2 · derivative.exercise_date: This option is scheduled to vest and become exercisable in 48 equal monthly installments occurring on the completion of each successive month of the Reporting Person's service to the Issuer following January 14, 2022.

Read SEC document
January 14, 2022 Filed Jan 19, 2022 16:52 UTC
Rajangam KanyaChief Medical Officer
GrantCommon Stock 12,800 $0.00 $0.00
Disclosure

SEC source: 0001209191-22-003756 · doc4.xml · nonDerivative · entry 1

Rajangam Kanya · CIK 0001816676 · Chief Medical Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 12,800

F1 · shares: Represents Restricted Stock Units ("RSUs") which vest in four equal annual installments beginning on the first anniversary of the grant date. Each RSU represents a contingent right to receive one share of Common Stock of the Issuer.

Read SEC document
January 14, 2022 Filed Jan 19, 2022 21:53 UTC
HASTINGS PAUL JDirector · Chief Executive Officer
GrantStock Option (right to buy) · Derivative 251,100 $0.00 Strike: $12.14 $0.00
Disclosure

SEC source: 0001209191-22-003759 · doc4.xml · derivative · entry 2

HASTINGS PAUL J · CIK 0001309702 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 251,100

Underlying: Common Stock · 251,100 shares

Expires 2032-01-13

F3 · derivative.exercise_date: This option is scheduled to vest and become exercisable in 48 equal monthly installments occurring on the completion of each successive month of the Reporting Person's service to the Issuer following January 14, 2022.

Read SEC document
January 14, 2022 Filed Jan 19, 2022 21:53 UTC
HASTINGS PAUL JDirector · Chief Executive Officer
GrantCommon Stock 41,900 $0.00 $0.00
Disclosure

SEC source: 0001209191-22-003759 · doc4.xml · nonDerivative · entry 1

HASTINGS PAUL J · CIK 0001309702 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 260,961

F1 · shares: Represents Restricted Stock Units ("RSUs") which vest in four equal annual installments beginning on the first anniversary of the grant date. Each RSU represents a contingent right to receive one share of Common Stock of the Issuer.

F2 · balance_after: Includes 7,714 shares acquired upon early exercise of an option, which are subject to forfeiture until they vest.

Read SEC document
January 14, 2022 Filed Jan 19, 2022 16:51 UTC
Hager Alicia J.Chief Legal Officer
GrantStock Option (right to buy) · Derivative 20,000 $0.00 Strike: $12.14 $0.00
Disclosure

SEC source: 0001209191-22-003755 · doc4.xml · derivative · entry 3

Hager Alicia J. · CIK 0001553354 · Chief Legal Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 20,000

Underlying: Common Stock · 20,000 shares

Expires 2032-01-13

F2 · derivative.exercise_date: This option is scheduled to vest and become exercisable in 48 equal monthly installments occurring on the completion of each successive month of the Reporting Person's service to the Issuer following January 14, 2022.

Read SEC document
January 14, 2022 Filed Jan 19, 2022 16:51 UTC
Hager Alicia J.Chief Legal Officer
GrantStock Option (right to buy) · Derivative 76,800 $0.00 Strike: $12.14 $0.00
Disclosure

SEC source: 0001209191-22-003755 · doc4.xml · derivative · entry 2

Hager Alicia J. · CIK 0001553354 · Chief Legal Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 76,800

Underlying: Common Stock · 76,800 shares

Expires 2032-01-13

F2 · derivative.exercise_date: This option is scheduled to vest and become exercisable in 48 equal monthly installments occurring on the completion of each successive month of the Reporting Person's service to the Issuer following January 14, 2022.

Read SEC document
January 14, 2022 Filed Jan 19, 2022 16:51 UTC
Hager Alicia J.Chief Legal Officer
GrantCommon Stock 12,800 $0.00 $0.00
Disclosure

SEC source: 0001209191-22-003755 · doc4.xml · nonDerivative · entry 1

Hager Alicia J. · CIK 0001553354 · Chief Legal Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 12,800

F1 · shares: Represents Restricted Stock Units ("RSUs") which vest in four equal annual installments beginning on the first anniversary of the grant date. Each RSU represents a contingent right to receive one share of Common Stock of the Issuer.

Read SEC document
December 01, 2021 Filed Dec 3, 2021 17:02 UTC
Brandenberger RalphSr. VP, Technical Operations
Exercise / conversionStock Option (right to buy) · Derivative 2,037 $0.00 Strike: $3.89 $0.00
Disclosure

SEC source: 0001209191-21-067867 · doc4.xml · derivative · entry 9

Brandenberger Ralph · CIK 0001853197 · Sr. VP, Technical Operations

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 46,176

Underlying: Common Stock · 2,037 shares

Expires 2029-09-05

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The transactions reported in this Form 4 were effected automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person at least 90 days prior to the trading date.

F6 · derivative.exercise_date: The options exercised were fully vested. Unvested options will vest and become exercisable ratably in monthly installments until fully vested on September 5, 2023.

Read SEC document
December 01, 2021 Filed Dec 3, 2021 17:02 UTC
Brandenberger RalphSr. VP, Technical Operations
Exercise / conversionStock Option (right to buy) · Derivative 1,358 $0.00 Strike: $3.89 $0.00
Disclosure

SEC source: 0001209191-21-067867 · doc4.xml · derivative · entry 8

Brandenberger Ralph · CIK 0001853197 · Sr. VP, Technical Operations

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 30,784

Underlying: Common Stock · 1,358 shares

Expires 2029-09-05

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The transactions reported in this Form 4 were effected automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person at least 90 days prior to the trading date.

F5 · derivative.exercise_date: The options exercised were fully vested. Unvested options will vest and become exercisable ratably in monthly installments until fully vested on July 1, 2024.

Read SEC document
December 01, 2021 Filed Dec 3, 2021 17:02 UTC
Brandenberger RalphSr. VP, Technical Operations
Exercise / conversionStock Option (right to buy) · Derivative 405 $0.00 Strike: $4.77 $0.00
Disclosure

SEC source: 0001209191-21-067867 · doc4.xml · derivative · entry 7

Brandenberger Ralph · CIK 0001853197 · Sr. VP, Technical Operations

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 9,190

Underlying: Common Stock · 405 shares

Expires 2029-05-10

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The transactions reported in this Form 4 were effected automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person at least 90 days prior to the trading date.

F4 · derivative.exercise_date: The options exercised were fully vested. Unvested options will vest and become exercisable ratably in monthly installments until fully vested on December 6, 2022.

Read SEC document
December 01, 2021 Filed Dec 3, 2021 17:02 UTC
Brandenberger RalphSr. VP, Technical Operations
Exercise / conversionStock Option (right to buy) · Derivative 340 $0.00 Strike: $0.41 $0.00
Disclosure

SEC source: 0001209191-21-067867 · doc4.xml · derivative · entry 6

Brandenberger Ralph · CIK 0001853197 · Sr. VP, Technical Operations

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 7,707

Underlying: Common Stock · 340 shares

Expires 2028-07-18

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The transactions reported in this Form 4 were effected automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person at least 90 days prior to the trading date.

F3 · derivative.exercise_date: The options exercised were fully vested. Unvested options will vest and become exercisable ratably in monthly installments until fully vested on April 2, 2022.

Read SEC document
December 01, 2021 Filed Dec 3, 2021 17:02 UTC
Brandenberger RalphSr. VP, Technical Operations
SaleCommon Stock 4,140 $15.64 $64,749.60
Disclosure

SEC source: 0001209191-21-067867 · doc4.xml · nonDerivative · entry 5

Brandenberger Ralph · CIK 0001853197 · Sr. VP, Technical Operations

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

F1 · kind: The transactions reported in this Form 4 were effected automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person at least 90 days prior to the trading date.

F2 · price: This transaction was executed in multiple trades at prices ranging from $15.26 to $16.10. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Read SEC document
December 01, 2021 Filed Dec 3, 2021 17:02 UTC
Brandenberger RalphSr. VP, Technical Operations
Exercise / conversionCommon Stock 2,037 $3.89 $7,923.93
Disclosure

SEC source: 0001209191-21-067867 · doc4.xml · nonDerivative · entry 4

Brandenberger Ralph · CIK 0001853197 · Sr. VP, Technical Operations

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,140

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The transactions reported in this Form 4 were effected automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person at least 90 days prior to the trading date.

Read SEC document
December 01, 2021 Filed Dec 3, 2021 17:02 UTC
Brandenberger RalphSr. VP, Technical Operations
Exercise / conversionCommon Stock 1,358 $3.89 $5,282.62
Disclosure

SEC source: 0001209191-21-067867 · doc4.xml · nonDerivative · entry 3

Brandenberger Ralph · CIK 0001853197 · Sr. VP, Technical Operations

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,103

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The transactions reported in this Form 4 were effected automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person at least 90 days prior to the trading date.

Read SEC document
December 01, 2021 Filed Dec 3, 2021 17:02 UTC
Brandenberger RalphSr. VP, Technical Operations
Exercise / conversionCommon Stock 405 $4.77 $1,931.85
Disclosure

SEC source: 0001209191-21-067867 · doc4.xml · nonDerivative · entry 2

Brandenberger Ralph · CIK 0001853197 · Sr. VP, Technical Operations

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 745

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The transactions reported in this Form 4 were effected automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person at least 90 days prior to the trading date.

Read SEC document
December 01, 2021 Filed Dec 3, 2021 17:02 UTC
Brandenberger RalphSr. VP, Technical Operations
Exercise / conversionCommon Stock 340 $0.41 $139.40
Disclosure

SEC source: 0001209191-21-067867 · doc4.xml · nonDerivative · entry 1

Brandenberger Ralph · CIK 0001853197 · Sr. VP, Technical Operations

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 340

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The transactions reported in this Form 4 were effected automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person at least 90 days prior to the trading date.

Read SEC document
September 29, 2021 Filed Oct 1, 2021 20:35 UTC
HASTINGS PAUL JDirector · Chief Executive Officer
SaleCommon Stock 223 $26.53 $5,916.19
Disclosure

SEC source: 0000899243-21-038637 · doc4.xml · nonDerivative · entry 2

HASTINGS PAUL J · CIK 0001309702 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 219,061

F1 · kind: The transactions reported in this Form 4 were effected automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person at least 90 days prior to the trading date.

F3 · balance_after: Includes 19,285 shares acquired upon early exercise of an option, which are subject to forfeiture until they vest.

Read SEC document
September 29, 2021 Filed Oct 1, 2021 20:35 UTC
HASTINGS PAUL JDirector · Chief Executive Officer
SaleCommon Stock 8,277 $27.20 $225,134.40
Disclosure

SEC source: 0000899243-21-038637 · doc4.xml · nonDerivative · entry 1

HASTINGS PAUL J · CIK 0001309702 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 219,284

F1 · kind: The transactions reported in this Form 4 were effected automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person at least 90 days prior to the trading date.

F2 · price: This transaction was executed in multiple trades at prices ranging from $26.65 to $27.58, inclusive. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

F3 · balance_after: Includes 19,285 shares acquired upon early exercise of an option, which are subject to forfeiture until they vest.

Read SEC document
September 01, 2021 Filed Sep 2, 2021 20:52 UTC Exercise / conversionStock Option (right to buy) · Derivative 2,037 $0.00 Strike: $3.89 $0.00
Disclosure

SEC source: 0000899243-21-035000 · doc4.xml · derivative · entry 9

Brandenberger Ralph · CIK 0001853197 · See Remarks

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 48,213

Underlying: Common Stock · 2,037 shares

Expires 2029-09-05

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The transactions reported in this Form 4 were effected automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person at least 90 days prior to the trading date.

F5 · derivative.exercise_date: The options exercised were fully vested. Unvested options will vest and become exercisable ratably in monthly installments until fully vested on September 5, 2023.

Read SEC document
September 01, 2021 Filed Sep 2, 2021 20:52 UTC Exercise / conversionStock Option (right to buy) · Derivative 1,358 $0.00 Strike: $3.89 $0.00
Disclosure

SEC source: 0000899243-21-035000 · doc4.xml · derivative · entry 8

Brandenberger Ralph · CIK 0001853197 · See Remarks

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 32,142

Underlying: Common Stock · 1,358 shares

Expires 2029-09-05

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The transactions reported in this Form 4 were effected automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person at least 90 days prior to the trading date.

F4 · derivative.exercise_date: The options exercised were fully vested. Unvested options will vest and become exercisable ratably in monthly installments until fully vested on July 1, 2024.

Read SEC document
September 01, 2021 Filed Sep 2, 2021 20:52 UTC Exercise / conversionStock Option (right to buy) · Derivative 405 $0.00 Strike: $4.77 $0.00
Disclosure

SEC source: 0000899243-21-035000 · doc4.xml · derivative · entry 7

Brandenberger Ralph · CIK 0001853197 · See Remarks

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 9,595

Underlying: Common Stock · 405 shares

Expires 2029-05-10

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The transactions reported in this Form 4 were effected automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person at least 90 days prior to the trading date.

F3 · derivative.exercise_date: The options exercised were fully vested. Unvested options will vest and become exercisable ratably in monthly installments until fully vested on December 6, 2022.

Read SEC document
September 01, 2021 Filed Sep 2, 2021 20:52 UTC Exercise / conversionStock Option (right to buy) · Derivative 340 $0.00 Strike: $0.41 $0.00
Disclosure

SEC source: 0000899243-21-035000 · doc4.xml · derivative · entry 6

Brandenberger Ralph · CIK 0001853197 · See Remarks

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 8,047

Underlying: Common Stock · 340 shares

Expires 2028-07-18

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The transactions reported in this Form 4 were effected automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person at least 90 days prior to the trading date.

F2 · derivative.exercise_date: The options exercised were fully vested. Unvested options will vest and become exercisable ratably in monthly installments until fully vested on April 2, 2022.

Read SEC document
September 01, 2021 Filed Sep 2, 2021 20:52 UTC SaleCommon Stock 4,140 $32.08 $132,811.20
Disclosure

SEC source: 0000899243-21-035000 · doc4.xml · nonDerivative · entry 5

Brandenberger Ralph · CIK 0001853197 · See Remarks

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

F1 · kind: The transactions reported in this Form 4 were effected automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person at least 90 days prior to the trading date.

Read SEC document
September 01, 2021 Filed Sep 2, 2021 20:52 UTC Exercise / conversionCommon Stock 2,037 $3.89 $7,923.93
Disclosure

SEC source: 0000899243-21-035000 · doc4.xml · nonDerivative · entry 4

Brandenberger Ralph · CIK 0001853197 · See Remarks

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,140

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The transactions reported in this Form 4 were effected automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person at least 90 days prior to the trading date.

Read SEC document
September 01, 2021 Filed Sep 2, 2021 20:52 UTC Exercise / conversionCommon Stock 1,358 $3.89 $5,282.62
Disclosure

SEC source: 0000899243-21-035000 · doc4.xml · nonDerivative · entry 3

Brandenberger Ralph · CIK 0001853197 · See Remarks

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,103

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The transactions reported in this Form 4 were effected automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person at least 90 days prior to the trading date.

Read SEC document
September 01, 2021 Filed Sep 2, 2021 20:52 UTC Exercise / conversionCommon Stock 405 $4.77 $1,931.85
Disclosure

SEC source: 0000899243-21-035000 · doc4.xml · nonDerivative · entry 2

Brandenberger Ralph · CIK 0001853197 · See Remarks

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 745

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The transactions reported in this Form 4 were effected automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person at least 90 days prior to the trading date.

Read SEC document
September 01, 2021 Filed Sep 2, 2021 20:52 UTC Exercise / conversionCommon Stock 340 $0.41 $139.40
Disclosure

SEC source: 0000899243-21-035000 · doc4.xml · nonDerivative · entry 1

Brandenberger Ralph · CIK 0001853197 · See Remarks

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 340

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The transactions reported in this Form 4 were effected automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person at least 90 days prior to the trading date.

Read SEC document
August 05, 2021 Filed Aug 9, 2021 17:17 UTC
Rajangam KanyaChief Medical Officer
Exercise / conversionStock Option (right to buy) · Derivative 10,000 $0.00 Strike: $0.41 $0.00
Disclosure

SEC source: 0000899243-21-032196 · doc4.xml · derivative · entry 3

Rajangam Kanya · CIK 0001816676 · Chief Medical Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 44,054

Underlying: Common Stock · 10,000 shares

Expires 2028-12-06

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The transactions reported in this Form 4 were effected automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person at least 90 days prior to the trading date.

F3 · derivative.exercise_date: The options exercised were fully vested. Unvested options will vest and become exercisable ratably in monthly installments until fully vested on December 3, 2022.

Read SEC document
August 05, 2021 Filed Aug 9, 2021 17:17 UTC
Rajangam KanyaChief Medical Officer
SaleCommon Stock 10,000 $37.28 $372,800.00
Disclosure

SEC source: 0000899243-21-032196 · doc4.xml · nonDerivative · entry 2

Rajangam Kanya · CIK 0001816676 · Chief Medical Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

F1 · kind: The transactions reported in this Form 4 were effected automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person at least 90 days prior to the trading date.

F2 · price: This transaction was executed in multiple trades at prices ranging from $37.02 to $37.63, inclusive. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transaction was effected.

Read SEC document
August 05, 2021 Filed Aug 9, 2021 17:17 UTC
Rajangam KanyaChief Medical Officer
Exercise / conversionCommon Stock 10,000 $0.41 $4,100.00
Disclosure

SEC source: 0000899243-21-032196 · doc4.xml · nonDerivative · entry 1

Rajangam Kanya · CIK 0001816676 · Chief Medical Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 10,000

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The transactions reported in this Form 4 were effected automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person at least 90 days prior to the trading date.

Read SEC document
August 02, 2021 Filed Aug 4, 2021 16:50 UTC
Trager JamesChief Scientific Officer
Exercise / conversionStock Option (right to buy) · Derivative 2,250 $0.00 Strike: $3.89 $0.00
Disclosure

SEC source: 0000899243-21-031622 · doc4.xml · derivative · entry 3

Trager James · CIK 0001816549 · Chief Scientific Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 55,412

Underlying: Common Stock · 2,250 shares

Expires 2029-09-05

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The transactions reported in this Form 4 were effected automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person at least 90 days prior to the trading date.

F2 · derivative.exercise_date: This option originally covered 62,162 shares of NKTX common stock and was scheduled to vest and become exercisable in 48 equal monthly installments occurring on the completion of each successive month of the Reporting Person's service to the Issuer following July 1, 2020.

Read SEC document
August 02, 2021 Filed Aug 4, 2021 16:50 UTC
Trager JamesChief Scientific Officer
SaleCommon Stock 3,600 $31.53 $113,508.00
Disclosure

SEC source: 0000899243-21-031622 · doc4.xml · nonDerivative · entry 2

Trager James · CIK 0001816549 · Chief Scientific Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 44,372

F1 · kind: The transactions reported in this Form 4 were effected automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person at least 90 days prior to the trading date.

Read SEC document
August 02, 2021 Filed Aug 4, 2021 16:50 UTC
Trager JamesChief Scientific Officer
Exercise / conversionCommon Stock 2,250 $3.89 $8,752.50
Disclosure

SEC source: 0000899243-21-031622 · doc4.xml · nonDerivative · entry 1

Trager James · CIK 0001816549 · Chief Scientific Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 47,972

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The transactions reported in this Form 4 were effected automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person at least 90 days prior to the trading date.

Read SEC document
July 01, 2021 Filed Jul 6, 2021 17:11 UTC
Mahmood NadirSee Remarks
Exercise / conversionStock Option (right to buy) · Derivative 3,500 $0.00 Strike: $3.89 $0.00
Disclosure

SEC source: 0000899243-21-027552 · doc4.xml · derivative · entry 3

Mahmood Nadir · CIK 0001816598 · See Remarks

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 70,743

Underlying: Common Stock · 3,500 shares

Expires 2029-09-05

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The transactions reported in this Form 4 were effected automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person at least 90 days prior to the trading date.

F3 · derivative.exercise_date: The options exercised were fully vested. Unvested options will vest and become exercisable ratably in monthly installments until fully vested on September 5, 2023.

Read SEC document
July 01, 2021 Filed Jul 6, 2021 17:11 UTC
Mahmood NadirSee Remarks
SaleCommon Stock 6,500 $31.71 $206,115.00
Disclosure

SEC source: 0000899243-21-027552 · doc4.xml · nonDerivative · entry 2

Mahmood Nadir · CIK 0001816598 · See Remarks

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 27,288

F1 · kind: The transactions reported in this Form 4 were effected automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person at least 90 days prior to the trading date.

F2 · balance_after: Includes 5,293 shares acquired upon early exercise of an option, which are subject to forfeiture until they vest.

Read SEC document
July 01, 2021 Filed Jul 6, 2021 17:11 UTC
Mahmood NadirSee Remarks
Exercise / conversionCommon Stock 3,500 $3.89 $13,615.00
Disclosure

SEC source: 0000899243-21-027552 · doc4.xml · nonDerivative · entry 1

Mahmood Nadir · CIK 0001816598 · See Remarks

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 33,788

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The transactions reported in this Form 4 were effected automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person at least 90 days prior to the trading date.

F2 · balance_after: Includes 5,293 shares acquired upon early exercise of an option, which are subject to forfeiture until they vest.

Read SEC document
June 21, 2021 Filed Jun 23, 2021 20:05 UTC
HASTINGS PAUL JDirector · Chief Executive Officer
SaleCommon Stock 3,807 $26.89 $102,370.23
Disclosure

SEC source: 0000899243-21-025505 · doc4.xml · nonDerivative · entry 2

HASTINGS PAUL J · CIK 0001309702 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 227,561

F1 · kind: The transactions reported in this Form 4 were effected automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person at least 90 days prior to the trading date.

F3 · price: This transaction was executed in multiple trades at prices ranging from $26.74 to $27.18. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

F4 · balance_after: Includes 30,856 shares acquired upon early exercise of an option, which are subject to forfeiture until they vest.

Read SEC document
June 21, 2021 Filed Jun 23, 2021 20:05 UTC
HASTINGS PAUL JDirector · Chief Executive Officer
SaleCommon Stock 4,693 $26.39 $123,848.27
Disclosure

SEC source: 0000899243-21-025505 · doc4.xml · nonDerivative · entry 1

HASTINGS PAUL J · CIK 0001309702 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 231,368

F1 · kind: The transactions reported in this Form 4 were effected automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person at least 90 days prior to the trading date.

F2 · price: This transaction was executed in multiple trades at prices ranging from $25.72 to $26.71. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

F4 · balance_after: Includes 30,856 shares acquired upon early exercise of an option, which are subject to forfeiture until they vest.

Read SEC document
June 16, 2021 Filed Jun 17, 2021 18:06 UTC
Mahmood NadirSee Remarks
Exercise / conversionStock Option (right to buy) · Derivative 1,800 $0.00 Strike: $3.89 $0.00
Disclosure

SEC source: 0000899243-21-024468 · doc4.xml · derivative · entry 2

Mahmood Nadir · CIK 0001816598 · See Remarks

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 47,522

Underlying: Common Stock · 1,800 shares

Expires 2029-09-05

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: The options exercised were fully vested. Unvested options will vest and become exercisable ratably in monthly installments until fully vested on July 1, 2024.

Read SEC document
June 16, 2021 Filed Jun 17, 2021 18:06 UTC
Mahmood NadirSee Remarks
Exercise / conversionCommon Stock 1,800 $3.89 $7,002.00
Disclosure

SEC source: 0000899243-21-024468 · doc4.xml · nonDerivative · entry 1

Mahmood Nadir · CIK 0001816598 · See Remarks

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 30,288

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · balance_after: Includes 5,822 shares acquired upon early exercise of an option, which are subject to forfeiture until they vest.

Read SEC document
June 13, 2021 Filed Jun 15, 2021 10:23 UTC GrantStock Option (right to buy) · Derivative 16,511 $0.00 Strike: $25.03 $0.00
Disclosure

SEC source: 0000899243-21-023793 · doc4.xml · derivative · entry 1

Azzam Fouad Oscar · CIK 0001816531 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 16,511

Underlying: Common Stock · 16,511 shares

Expires 2031-06-12

F1 · derivative.exercise_date: All shares subject to the option vest 100% on the first to occur of (i) June 13, 2022, or (ii) the day immediately preceding the first annual meeting of the Issuer's stockholders to occur after the date of grant of the award. Each grant, to the extent outstanding and otherwise unvested, will become fully vested should a "change in control" of the Issuer occur (as described in the applicable award agreement) or upon the Reporting Person's separation from service with the Issuer due to the Reporting Person's death or "disability" (as described in the applicable award agreement).

Read SEC document
June 13, 2021 Filed Jun 15, 2021 14:26 UTC GrantStock Option (right to buy) · Derivative 16,511 $0.00 Strike: $25.03 $0.00
Disclosure

SEC source: 0000899243-21-023799 · doc4.xml · derivative · entry 1

Scheiner Zachary · CIK 0001816523 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 16,511

Underlying: Common Stock · 16,511 shares

Expires 2031-06-12

F1 · derivative.exercise_date: All shares subject to the option vest 100% on the first to occur of (i) June 13, 2022, or (ii) the day immediately preceding the first annual meeting of the Issuer's stockholders to occur after the date of grant of the award. Each grant, to the extent outstanding and otherwise unvested, will become fully vested should a "change in control" of the Issuer occur (as described in the applicable award agreement) or upon the Reporting Person's separation from service with the Issuer due to the Reporting Person's death or "disability" (as described in the applicable award agreement).

Read SEC document
June 13, 2021 Filed Jun 15, 2021 14:26 UTC GrantStock Option (right to buy) · Derivative 16,511 $0.00 Strike: $25.03 $0.00
Disclosure

SEC source: 0000899243-21-023798 · doc4.xml · derivative · entry 1

PATTERSON LEONE D · CIK 0001233539 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 16,511

Underlying: Common Stock · 16,511 shares

Expires 2031-06-12

F1 · derivative.exercise_date: All shares subject to the option vest 100% on the first to occur of (i) June 13, 2022, or (ii) the day immediately preceding the first annual meeting of the Issuer's stockholders to occur after the date of grant of the award. Each grant, to the extent outstanding and otherwise unvested, will become fully vested should a "change in control" of the Issuer occur (as described in the applicable award agreement) or upon the Reporting Person's separation from service with the Issuer due to the Reporting Person's death or "disability" (as described in the applicable award agreement).

Read SEC document
June 13, 2021 Filed Jun 15, 2021 14:25 UTC GrantStock Option (right to buy) · Derivative 16,511 $0.00 Strike: $25.03 $0.00
Disclosure

SEC source: 0000899243-21-023797 · doc4.xml · derivative · entry 1

Shawver Laura · CIK 0001551891 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 16,511

Underlying: Common Stock · 16,511 shares

Expires 2031-06-12

F1 · derivative.exercise_date: All shares subject to the option vest 100% on the first to occur of (i) June 13, 2022, or (ii) the day immediately preceding the first annual meeting of the Issuer's stockholders to occur after the date of grant of the award. Each grant, to the extent outstanding and otherwise unvested, will become fully vested should a "change in control" of the Issuer occur (as described in the applicable award agreement) or upon the Reporting Person's separation from service with the Issuer due to the Reporting Person's death or "disability" (as described in the applicable award agreement).

Read SEC document
June 13, 2021 Filed Jun 15, 2021 14:29 UTC GrantStock Option (right to buy) · Derivative 16,511 $0.00 Strike: $25.03 $0.00
Disclosure

SEC source: 0000899243-21-023803 · doc4.xml · derivative · entry 1

George Simeon · CIK 0001595117 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 16,511

Underlying: Common Stock · 16,511 shares

Expires 2031-06-12

F1 · derivative.exercise_date: All shares subject to the option vest 100% on the first to occur of (i) June 13, 2022, or (ii) the day immediately preceding the first annual meeting of the Issuer's stockholders to occur after the date of grant of the award. Each grant, to the extent outstanding and otherwise unvested, will become fully vested should a "change in control" of the Issuer occur (as described in the applicable award agreement) or upon the Reporting Person's separation from service with the Issuer due to the Reporting Person's death or "disability" (as described in the applicable award agreement).

Read SEC document
June 13, 2021 Filed Jun 15, 2021 14:29 UTC GrantStock Option (right to buy) · Derivative 16,511 $0.00 Strike: $25.03 $0.00
Disclosure

SEC source: 0000899243-21-023802 · doc4.xml · derivative · entry 1

Dybbs Michael · CIK 0001601264 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 16,511

Underlying: Common Stock · 16,511 shares

Expires 2031-06-12

F1 · derivative.exercise_date: All shares subject to the option vest 100% on the first to occur of (i) June 13, 2022, or (ii) the day immediately preceding the first annual meeting of the Issuer's stockholders to occur after the date of grant of the award. Each grant, to the extent outstanding and otherwise unvested, will become fully vested should a "change in control" of the Issuer occur (as described in the applicable award agreement) or upon the Reporting Person's separation from service with the Issuer due to the Reporting Person's death or "disability" (as described in the applicable award agreement).

Read SEC document
June 13, 2021 Filed Jun 15, 2021 20:25 UTC GrantStock Option (right to buy) · Derivative 16,511 $0.00 Strike: $25.03 $0.00
Disclosure

SEC source: 0001209191-21-040587 · doc4.xml · derivative · entry 1

Behbahani Ali · CIK 0001613867 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 16,511

Underlying: Common Stock · 16,511 shares

Expires 2031-06-12

F1 · derivative.exercise_date: All shares subject to the option vest 100% on the first to occur of (i) June 13, 2022, or (ii) the day immediately preceding the first annual meeting of the Issuer's stockholders to occur after the date of grant of the award. Each grant, to the extent outstanding and otherwise unvested, will become fully vested should a "change in control" of the Issuer occur (as described in the applicable award agreement) or upon the Reporting Person's separation from service with the Issuer due to the Reporting Person's death or "disability" (as described in the applicable award agreement).

Read SEC document
June 02, 2021 Filed Jun 4, 2021 14:29 UTC Exercise / conversionStock Option (right to buy) · Derivative 2,037 $0.00 Strike: $3.89 $0.00
Disclosure

SEC source: 0000899243-21-021981 · doc4.xml · derivative · entry 9

Brandenberger Ralph · CIK 0001853197 · See Remarks

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 50,250

Underlying: Common Stock · 2,037 shares

Expires 2029-09-05

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The transactions reported in this Form 4 were effected automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person at least 90 days prior to the trading date.

F5 · derivative.exercise_date: The option is vested and exercisable as to 18,561 shares, and the remaining shares will vest and become exercisable ratably in monthly installments until fully vested on September 5, 2023.

Read SEC document
June 02, 2021 Filed Jun 4, 2021 14:29 UTC Exercise / conversionStock Option (right to buy) · Derivative 1,358 $0.00 Strike: $3.89 $0.00
Disclosure

SEC source: 0000899243-21-021981 · doc4.xml · derivative · entry 8

Brandenberger Ralph · CIK 0001853197 · See Remarks

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 33,500

Underlying: Common Stock · 1,358 shares

Expires 2029-09-05

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The transactions reported in this Form 4 were effected automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person at least 90 days prior to the trading date.

F4 · derivative.exercise_date: The option is vested and exercisable as to 5,583 shares, and the remaining shares will vest and become exercisable ratably in monthly installments until fully vested on July 1, 2024.

Read SEC document
June 02, 2021 Filed Jun 4, 2021 14:29 UTC Exercise / conversionStock Option (right to buy) · Derivative 405 $0.00 Strike: $4.77 $0.00
Disclosure

SEC source: 0000899243-21-021981 · doc4.xml · derivative · entry 7

Brandenberger Ralph · CIK 0001853197 · See Remarks

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 10,000

Underlying: Common Stock · 405 shares

Expires 2029-05-10

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The transactions reported in this Form 4 were effected automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person at least 90 days prior to the trading date.

F3 · derivative.exercise_date: The option is vested and exercisable as to 5,721 shares, and the remaining shares will vest and become exercisable ratably in monthly installments until fully vested on December 6, 2022.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.